DK296189D0 - Nucleinsyresekvenser, som koder for peptidsekvenser af carcinoembryonisk antigen-familien - Google Patents

Nucleinsyresekvenser, som koder for peptidsekvenser af carcinoembryonisk antigen-familien

Info

Publication number
DK296189D0
DK296189D0 DK296189A DK296189A DK296189D0 DK 296189 D0 DK296189 D0 DK 296189D0 DK 296189 A DK296189 A DK 296189A DK 296189 A DK296189 A DK 296189A DK 296189 D0 DK296189 D0 DK 296189D0
Authority
DK
Denmark
Prior art keywords
nucleic acid
carcinoembryonic antigen
antigen family
acid sequences
coding peptide
Prior art date
Application number
DK296189A
Other languages
English (en)
Other versions
DK175605B1 (da
DK296189A (da
Inventor
Thomas R Barnett
James J Elting
Michael E Kamarck
Axel Kretschmer
Original Assignee
Molecular Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Diagnostics Inc filed Critical Molecular Diagnostics Inc
Publication of DK296189D0 publication Critical patent/DK296189D0/da
Publication of DK296189A publication Critical patent/DK296189A/da
Application granted granted Critical
Publication of DK175605B1 publication Critical patent/DK175605B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3007—Carcino-embryonic Antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK198902961A 1988-06-16 1989-06-15 Nucleinsyresekvenser, som koder for peptidsekvenser af carcinoembryonisk antigen-familien, en kopierbar rekombinant-kloningsbærer indeholdende en sådan nucleinsyresekvens, en celle indeholdende en sådan kloningsbærer, et protein indeholdende en ....... DK175605B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US20767888A 1988-06-16 1988-06-16
US20767888 1988-06-16
US07/274,107 US5122599A (en) 1986-08-13 1988-11-21 CDNAS coding for members of the carcinoembryonic antigen family
US27410788 1988-11-21

Publications (3)

Publication Number Publication Date
DK296189D0 true DK296189D0 (da) 1989-06-15
DK296189A DK296189A (da) 1989-12-17
DK175605B1 DK175605B1 (da) 2004-12-20

Family

ID=26902468

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198902961A DK175605B1 (da) 1988-06-16 1989-06-15 Nucleinsyresekvenser, som koder for peptidsekvenser af carcinoembryonisk antigen-familien, en kopierbar rekombinant-kloningsbærer indeholdende en sådan nucleinsyresekvens, en celle indeholdende en sådan kloningsbærer, et protein indeholdende en .......

Country Status (13)

Country Link
US (1) US5122599A (da)
EP (1) EP0346710B1 (da)
JP (1) JPH02107190A (da)
AU (1) AU628348B2 (da)
CA (1) CA1340787C (da)
DE (1) DE68910590T2 (da)
DK (1) DK175605B1 (da)
ES (1) ES2059621T3 (da)
FI (1) FI892910A (da)
IE (1) IE62161B1 (da)
IL (1) IL90594A (da)
NO (1) NO892220L (da)
NZ (1) NZ229514A (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346999A (en) * 1985-01-18 1994-09-13 Applied Biosystems, Inc. Method of nucleic acid extraction
US5274087A (en) * 1986-08-13 1993-12-28 Molecular Diagnostics, Inc. cDNA coding for carcinoembryonic antigen (CEA)
US5200316A (en) * 1990-02-15 1993-04-06 Miles Inc. Immunoassay methods using noncross reactive cea gene family members antibodies
US6765087B1 (en) * 1992-08-21 2004-07-20 Vrije Universiteit Brussel Immunoglobulins devoid of light chains
CA2116640A1 (en) * 1993-03-25 1994-09-26 Alexey Terskikh Carcinoembryonic antigen derivatives
US6391550B1 (en) * 1996-09-19 2002-05-21 Affymetrix, Inc. Identification of molecular sequence signatures and methods involving the same
EP0943012A4 (en) * 1996-09-19 2004-06-30 Affymetrix Inc IDENTIFICATION OF MOLECULAR SEQUENCE SIGNATURES AND RELATED METHODS
US20070048860A1 (en) * 1997-10-10 2007-03-01 The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services Carcinoembryonic antigen (CEA) peptides
CA2363009A1 (en) * 1999-03-01 2000-09-08 Incyte Pharmaceuticals, Inc. Leukocyte- and blood-associated proteins
EP1964573B1 (en) 1999-10-22 2014-11-26 Aventis Pasteur Limited Method of inducing and/or enhancing an immune response to tumor antigens
US6949629B2 (en) * 2002-03-13 2005-09-27 Aspenbio, Inc. Methods for purifying selected CEA family member proteins
CN1658899B (zh) 2002-04-09 2013-01-02 安万特巴斯德有限公司 经修饰的cea核酸及表达载体
WO2005035773A2 (en) * 2003-10-08 2005-04-21 Sanofi Pasteur, Inc. Modified cea /b7 vector
WO2004092216A1 (en) * 2003-04-15 2004-10-28 Trangene S.A. Carcinoembryonic antigen (cea) lacking a signal peptide, nucleic acid encoding it and fusion of cea with a t cell epitope and their use for the treatment and/or prophylaxis of cancer
US8188244B2 (en) 2004-02-11 2012-05-29 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa Carcinoembryonic antigen fusions and uses thereof
JP4852887B2 (ja) * 2004-05-28 2012-01-11 凸版印刷株式会社 掲示板
EP1880206B1 (en) * 2005-05-09 2012-11-14 Affymetrix, Inc. Multiplex capture of nucleic acids
US8632970B2 (en) 2005-05-09 2014-01-21 Affymetrix, Inc. Multiplex capture of nucleic acids
CA2607221A1 (en) * 2005-05-12 2006-11-23 Panomics, Inc. Multiplex branched-chain dna assays
CN104673903B (zh) * 2005-06-20 2018-11-13 领先细胞医疗诊断有限公司 检测单个细胞中的核酸和鉴定异质大细胞群中罕见细胞的方法
US7927798B2 (en) * 2005-10-05 2011-04-19 Panomics, Inc. Detection of nucleic acids from whole blood
WO2009114207A2 (en) 2008-03-14 2009-09-17 Sanofi Pasteur Biologics Co. Replication-defective flavivirus vaccines and vaccine vectors
EP2271770B1 (en) * 2008-03-31 2018-08-22 Genentech, Inc. Compositions and methods for treating and diagnosing asthma
CN107365847A (zh) 2010-10-21 2017-11-21 领先细胞医疗诊断有限公司 用于原位检测核酸的超灵敏方法
CN105175542B (zh) 2010-12-16 2018-12-18 弗·哈夫曼-拉罗切有限公司 与th2抑制相关的诊断和治疗
WO2014140938A2 (en) 2013-03-14 2014-09-18 Centre Hospitalier Universitaire Vaudois Immunological methods
US9753036B2 (en) 2014-04-29 2017-09-05 Edp Biotech Corporation Methods and compositions for screening and detecting biomarkers
DK3362462T3 (da) 2015-10-12 2021-10-11 Advanced Cell Diagnostics Inc In situ-detektion af nukleotidvarianter i prøver med højt støjniveau, og sammensætninger og fremgangsmåder relateret dertil
KR102605505B1 (ko) 2016-09-28 2023-11-22 버베리안 노딕 에이/에스 폭스바이러스에서 이식유전자의 안정성을 강화시키는 조성물 및 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4228236A (en) * 1978-05-15 1980-10-14 Northwestern University Process of producing carcinoembryonic antigen
US4489167A (en) * 1981-06-02 1984-12-18 Baxter Travenol Laboratories, Inc. Methods and compositions for cancer detection
IL75994A0 (en) * 1985-08-01 1985-12-31 Israel Inst Biolog Res Process for the production of a substance for monitoring cancer patients
DE3787864T2 (de) * 1986-08-13 1994-02-10 Miles Inc Karzinoembryonisches Antigen kodierende cDNS.

Also Published As

Publication number Publication date
NO892220L (no) 1989-12-18
EP0346710A2 (en) 1989-12-20
AU3644389A (en) 1989-12-21
EP0346710B1 (en) 1993-11-10
DK175605B1 (da) 2004-12-20
EP0346710A3 (en) 1991-09-11
CA1340787C (en) 1999-10-12
ES2059621T3 (es) 1994-11-16
DK296189A (da) 1989-12-17
NO892220D0 (no) 1989-06-01
IE891945L (en) 1989-12-16
IE62161B1 (en) 1994-12-28
AU628348B2 (en) 1992-09-17
NZ229514A (en) 1991-05-28
IL90594A0 (en) 1990-01-18
FI892910A (fi) 1989-12-17
FI892910A0 (fi) 1989-06-14
JPH02107190A (ja) 1990-04-19
DE68910590T2 (de) 1994-03-17
US5122599A (en) 1992-06-16
IL90594A (en) 1997-11-20
DE68910590D1 (de) 1993-12-16

Similar Documents

Publication Publication Date Title
DK296189D0 (da) Nucleinsyresekvenser, som koder for peptidsekvenser af carcinoembryonisk antigen-familien
DK108589A (da) Chimere antistoffer rettet mod humant carcinoembryonalt antigen samt dna-sekvenser, der koder for saadanne antistoffer
DK532184D0 (da) Antigene aminosyresekvenser
NO893054D0 (no) Fremgangsmaate for utdypning av nukleotidsekvenser.
FI895201A0 (fi) Oevervakningsanordning foer en byggnads tekniska drift.
DK724788A (da) Fotohaerdeligt, ionomert cementsystem
DK108189A (da) Chimere antistoffer rettet mod humant carcinoembryonalt antigen og metal-chelater samt dna-sekvenser, der koder for saadanne antistoffer
FI901256A0 (fi) Formulationer som administreras genom slemhinna.
DK168080C (da) Fremgangsmaade til fremstilling af lavmolekylaere peptider
DE3789413D1 (de) Lymphokin-ähnliche Peptide.
IT8419343A0 (it) Antigene di peptide protettivo.
DK58887A (da) Autoantigene vacciner
DK163062C (da) Antigen, immunogen, proteinholdig vaccine imod coccidiose
IT1198289B (it) Antigene di flavvirus
NO881384D0 (no) Peptider.
NO885108D0 (no) Peptider.
FI970071A0 (fi) Eristetty nukleiinihapposekvenssi, joka koodaa HLA-A2:n esittämää tuumorihyljintäantigeeniä
FI861691A0 (fi) En ny tumoerassocierad antigen.
DE3672140D1 (de) Polyimid - poly ( arylketon ) mischungen.
DE3586765D1 (de) Immunogenische hav-peptide.
FI911311A0 (fi) Monoklonala antikroppar som haemmar inverkan av gram-negativa bakteriers endotoxin.
DE3869884D1 (de) Polysiloxanmodifizierter zement.
DE3676481D1 (de) Zentral angeordnete phasenkodierung.
DE3685636D1 (de) Lysozymbetreffende peptide.
NO872386L (no) Peptider.

Legal Events

Date Code Title Description
PUP Patent expired